ASRT vs PG · rev $125.0M vs P/E 25, rev $84.28B
Assertio Therapeutics Inc (ASRT) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
ASRT currently screens at market cap $151.5M. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the ASRT and PG stock pages for the full models.
Not investment advice.